Deconstructing nucleotide binding activity of the Mdm2 RING domain

被引:10
作者
Priest, Christina [1 ]
Prives, Carol [1 ]
Poyurovsky, Masha V. [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
UBIQUITIN LIGASE; FINGER DOMAIN; NUCLEOLAR-LOCALIZATION; P53; UBIQUITINATION; TUMOR-SUPPRESSOR; ONCOPROTEIN; RNA; DEGRADATION; INHIBITORS; PROTEINS;
D O I
10.1093/nar/gkq669
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mdm2, a central negative regulator of the p53 tumor suppressor, possesses a Really Interesting New Gene (RING) domain within its C-terminus. In addition to E3 ubiquitin ligase activity, the Mdm2 RING preferentially binds adenine base nucleotides, and such binding leads to a conformational change in the Mdm2 C-terminus. Here, we present further biochemical analysis of the nucleotide-Mdm2 interaction. We have found that MdmX, an Mdm2 family member with high sequence homology, binds adenine nucleotides with similar affinity and specificity as Mdm2, suggesting that residues involved in nucleotide binding may be conserved between the two proteins and adenosine triphosphate (ATP) binding may have similar functional consequences for both Mdm family members. By generating and testing a series of proteins with deletions and substitution mutations within the Mdm2 RING, we mapped the specific adenine nucleotide binding region of Mdm2 to residues 429-484, encompassing the minimal RING domain. Using a series of ATP derivatives, we demonstrate that phosphate coordination by the Mdm2 P-loop contributes to, but is not primarily responsible for, ATP binding. Additionally, we have identified the 2' and 3' hydroxyls of the ribose and the C6 amino group of the adenine base moiety as being essential for binding.
引用
收藏
页码:7587 / 7598
页数:12
相关论文
共 47 条
[1]   Stress signals utilize multiple pathways to stabilize p53 [J].
Ashcroft, M ;
Taya, Y ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3224-3233
[2]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315
[3]   Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[4]   ORAL ANTILYMPHOCYTE ACTIVITY AND INDUCTION OF APOPTOSIS BY 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE [J].
CARSON, DA ;
WASSON, DB ;
ESPARZA, LM ;
CARRERA, CJ ;
KIPPS, TJ ;
COTTAM, HB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2970-2974
[5]   MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS [J].
CHEN, JD ;
MARECHAL, V ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4107-4114
[6]  
DEISENROTH C, 2010, ONCOGENE, P1
[7]   The MDM2 oncoprotein binds specifically to RNA through its RING finger domain [J].
Elenbaas, B ;
Dobbelstein, M ;
Roth, J ;
Shenk, T ;
Levine, AJ .
MOLECULAR MEDICINE, 1996, 2 (04) :439-451
[8]   The participation of metals in the mechanism of the F1-ATPase [J].
Frasch, WD .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2000, 1458 (2-3) :310-325
[9]   Small Molecule Aurora Kinases Inhibitors [J].
Garuti, Laura ;
Roberti, Marinella ;
Bottegoni, Giovanni .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (16) :1949-1963
[10]   Mutual dependence of MDM2 and MDMX in their functional inactivation of p53 [J].
Gu, JJ ;
Kawai, H ;
Nie, LG ;
Kitao, H ;
Wiederschain, D ;
Jochemsen, AG ;
Parant, J ;
Lozano, G ;
Yuan, ZM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) :19251-19254